Menu
Beta-O2 technologies is developing the ßAir, a Bio-artificial Pancreas (BAP) intended to cure Type 1 diabetes (TID).The ßAir BAP provides a viable and safe environment for pancreatic IOL inside a subcutaneously implanted bioreactor. Consequently, they can thrive, function like native IOL thus providing the body with the two essential hormones at the correct ratio.
MSCOMMS is a boutique Public Relations firm, with over 20 years of
experience in the B2B and B2C markets.
We are a service-oriented and results-driven team, providing our customers
with a tailor-made communications strategy for their unique needs.
We’ll identify your story and tell it right, to best support your communications goals
and the company’s business.